Actinium Showcases Targeted Conditioning Program with 2 Oral Presentations Highlighting Iomab-B and Pivotal Phase 3 SIERRA Trial at 2021 Transplantation & Cellular Therapy Annual Meeting ...Middle East

NEW YORK, Feb. 11, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today highlighted its presence at the 2021 Transplantation & Cellular Therapy (TCT) Annual Meeting, which is being held virtually from February 8th – 12th. The TCT...

Hence then, the article about actinium showcases targeted conditioning program with 2 oral presentations highlighting iomab b and pivotal phase 3 sierra trial at 2021 transplantation cellular therapy annual meeting was published today ( Thursday 11/02/2021 - 03:31 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Actinium Showcases Targeted Conditioning Program with 2 Oral Presentations Highlighting Iomab-B and Pivotal Phase 3 SIERRA Trial at 2021 Transplantation & Cellular Therapy Annual Meeting )

Also on site :

• Burnham to face battle with SEND parents over watering down reforms
• Benedict Cumberbatch Turns 50—And His Simple Truth About Happiness Might Change How You Think About It
• ‘Right to repair’ is coming to cars, but there’s still this big blind spot as consumers demand more autonomy